DarioHealth
The alliance merges DarioHealth's cardiometabolic and behavioral AI-powered health offering with GreenKey's system for managing obstructive sleep apnea.
Epicore Biosystems expands Series B to $32 million to advance sweat-sensing wearable technology.
The New York-based company also reported a 110% increase in fourth-quarter revenue in 2024 compared to Q4 2023 and a Q4 2024 net loss of $9.6 million.
The financing will be used to execute the company's long-term growth initiatives centered on high-margin, scalable recurring revenues across B2B and pharma channels.
The expansion includes prescribing capabilities and entry into the direct-to-consumer market.